低分子肝素与普通肝素预防枪伤性穿透性脑损伤后静脉血栓栓塞的效果比较
该回顾性研究基于创伤质量改进计划(2017-2019)数据,纳入2012例成人孤立性枪伤相关穿透性脑损伤患者,比较低分子肝素(LMWH)与普通肝素(UH)预防静脉血栓栓塞(VTE)的效果。风险调整后,LMWH与VTE odds降低51%相关(OR 0.49,95%CI 0.32-0.77),且不增加晚期神经外科减压或院内死亡风险。
要点
- LMWH较UH显著降低枪伤性穿透性脑损伤患者VTE风险(OR 0.49)。
- LMWH未增加晚期神经外科减压或院内死亡风险。
- 早期开颅/去骨瓣或未手术亚组中LMWH均优于UH。
核心结论
- 在枪伤相关穿透性脑损伤患者中,LMWH预防VTE的效果显著优于UH,且不增加神经外科干预风险,支持LMWH作为首选药物。
研究设计与样本
- 回顾性分析创伤质量改进计划(2017-2019)数据,纳入2012例成人(年龄≥16岁)孤立性枪伤相关穿透性脑损伤患者,于I级或II级创伤中心治疗。
主要发现
- 风险调整后,LMWH与UH相比VTE odds降低51%(OR 0.49,95%CI 0.32-0.77)。
- 亚组分析显示,早期开颅/去骨瓣患者中LMWH与VTE odds降低相关(OR 0.42,95%CI 0.23-0.74),未干预患者中亦相关(OR 0.41,95%CI 0.21-0.79)。
- 药物预防类型与晚期神经外科减压或院内死亡无显著关联。
关键数值与推荐
- 主要结局为VTE发生;次要结局为晚期神经外科减压需求和院内死亡。
- 采用分层逻辑回归模型,调整患者基线、损伤特征及VTE预防启动时机。
临床怎么用
- 对于枪伤相关穿透性脑损伤成人患者,可优先选用LMWH而非UH进行VTE药物预防。
- LMWH不增加晚期神经外科减压风险,但需结合个体化评估。
局限性
- 回顾性研究设计可能存在残余混杂。
- 仅纳入I级或II级创伤中心数据,外推性受限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Venous thromboembolism (VTE), including deep vein thrombosis and pulmonary embolism, is a major source of morbidity and mortality following firearm-related penetrating brain injury (PBI). Standard pharmacological prophylaxis against VTE includes the use of low-molecular-weight heparin (LMWH) or unfractionated heparin (UH). However, the comparative effectiveness of LMWH versus UH to prevent VTE in this population remains unclear. METHODS: A retrospective analysis was conducted using data from the Trauma Quality Improvement Program (2017-2019) to evaluate the effectiveness of LMWH versus UH in patients with PBI. Adult patients (age ≥ 16 years) with an isolated firearm-related PBI treated at a level I or II trauma center were included. The primary outcome was the occurrence of VTE. Secondary outcomes were the need for late neurosurgical decompression and in-hospital mortality. Hierarchical logistic regression models were used to evaluate the association between prophylaxis type and the outcomes, adjusting for patient baseline and injury characteristics, as well as timing of VTE prophylaxis initiation. Effect modification was evaluated to determine whether the observed associations varied between types of early neurosurgical intervention: craniotomy/craniectomy, intracranial monitor/drain placement, or no intervention. RESULTS: Among 2012 patients with isolated firearm-related PBI, LMWH was associated with 51% decreased odds of VTE compared with UH (OR 0.49, 95% CI 0.32-0.77) after risk adjustment. Subgroup analysis showed that LMWH, compared with UH, was associated with reduced odds of VTE in patients who underwent early craniotomy/craniectomy (OR 0.42, 95% CI 0.23-0.74) or no intervention (OR 0.41, 95% CI 0.21-0.79). The type of pharmacological VTE prophylaxis was not associated with the occurrence of late neurosurgical decompression or in-hospital mortality. CONCLUSIONS: In patients with firearm-related PBI, LMWH appears to be significantly more effective at preventing VTE compared with UH, without increasing the risk of neurosurgical intervention. These findings support the use of LMWH as the preferred agent for VTE prophylaxis after PBI.
引用
- Liu J, Myneni S, Tang L, et al. Effectiveness of low-molecular-weight heparin versus unfractionated heparin for venous thromboembolism prophylaxis after firearm-related penetrating brain injury. J Neurosurg. 2025. PMID: 41569916. doi:10.3171/2025.7.JNS251092
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。